# Advisory Committee on Immunization Practices (ACIP)
**Correction**
This notice was published in the *Federal Register* on February 1, 2012, Volume 77, Number 21, Page 5026. The matters to be discussed and times should read as follows:
*Matters To Be Discussed:* The agenda will include discussions on: meningococcal vaccine, hepatitis B vaccine, tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, influenza, vaccine supply, 13-valent pneumococcal conjugate vaccine, and measles-mumps-rubella (MMR) vaccine. Recommendation vote is scheduled for Tdap vaccine. Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
*Times and Dates:*
8 a.m.-5 p.m., February 22, 2012.
8 a.m.-12:30 p.m., February 23, 2012.
The Meeting is Web cast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: *http://www.cdc.gov/vaccines/recs/acip/.*
*Contact Person for More Information:* Stephanie B. Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS-A27, Atlanta, Georgia 30333, telephone: (404)639-8836; Email *[email protected]* .
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.